Table of contents:
- Carboplatin is a drug to treat cancer, such as advanced ovarian cancer or small cell lung cancer. This drug belongs to chemotherapy drugs that contain platinum
- What is Carboplatin
- Warning Before Using Carboplatin
- Dosage and Rules for Use of Carboplatin
- How to Use Carboplatin Correctly
- Interaction of Carboplatin with Other Drugs
- Side Effects and Dangers of Carboplatin
2023 Author: Autumn Gilbert | [email protected]. Last modified: 2023-11-27 07:39
Carboplatin is a drug to treat cancer, such as advanced ovarian cancer or small cell lung cancer. This drug belongs to chemotherapy drugs that contain platinum
Carboplatin will slow or stop the growth of cancer cells. This medicine will be administered in the hospital by a doctor or medical officer under the supervision of a doctor.
Carboplatin trademarks: Actoplatin, Carboplatin, Carbofon, DBL Carboplatin, Fuplatin, Kemobotin, Kemocarb, Sanbeplatin
What is Carboplatin
|Categories||Chemotherapy or anticancer drugs|
|Benefits||Treatment of certain cancers, such as ovarian cancer|
|Used by||Adults and children|
|Carboplatin for Pregnant and Breastfeeding Mothers||Category D: There is positive evidence of risks to the human fetus, but the benefits may outweigh the risks, for example in dealing with life-threatening situations.
Carboplatin is not known whether it can be absorbed into breast milk or not. If you are breastfeeding, do not use this medicine without consulting your doctor.
|Medicine Form||Injectable fluids or IV fluids|
Warning Before Using Carboplatin
Carboplatin is a drug that can only be used according to a doctor's prescription. Here are some things you need to pay attention to before using carboplatin:
- Tell your doctor about any allergies you have. This carboplatin should not be used by patients who are allergic to this drug or to oxaliplatin or cisplatin.
- Tell your doctor if you have kidney disease, liver disease, electrolyte disturbances, weakened immune system, or bone marrow disease, including those that cause anemia, leukopenia, or thrombocytopenia
- Tell your doctor if you are taking any other medicines, including supplements or herbal products.
- Tell your doctor that you are being treated with carboplatin before undergoing certain medical procedures or surgery.
- Tell your doctor if you are pregnant, breastfeeding or planning a pregnancy. This medicine should not be used by pregnant women or nursing mothers. Use effective contraception during treatment with carboplatin up to 6 months after the last dose.
- As much as possible, avoid close contact with people with infectious diseases that are easily transmitted, such as the flu, during treatment with carboplatin, because it can increase your risk of contracting it.
- Consult your doctor if you plan to vaccinate while undergoing treatment with carboplatin.
- See your doctor immediately if you have an allergic reaction to the drug, serious side effects, or an overdose, after taking carboplatin.
Dosage and Rules for Use of Carboplatin
The dose of carboplatin given by the doctor depends on the patient's condition, body surface area (LPT), and the patient's body response to therapy. Carboplatin will be given by injection into a vein (intravenous/IV).
In general, the following will describe the dose of carboplatin according to conditions and body surface area:
Condition: Advanced ovarian cancer or small cell lung cancer
- Adults: For adult patients who have never received previous treatment, the dose is 400 mg/m² LPT (body surface area), given by IV infusion over 15–60 minutes. The injection was repeated after 4 weeks or until the neutrophil level was 2,000 cells/mm3 and the platelet level was 100,000 cells/mm3blood. Meanwhile, for adult patients who have previously been treated with myelosuppressive therapy or patients with poor performance status, the dose is 300–320 mg/m² LPT.
Condition: Solid tumor
- Children: 300–600 mg/m²LPT every 4 weeks.
Condition: Brain tumor
- Children: 175 mg/m²LPT weekly for 4 weeks, followed by a recovery period of 2 weeks.
Condition: Bone sarcoma or soft tissue sarcoma
- Children: 400 mg/m²LPT per day for 2 days, every 21 days.
Condition: Preparation before bone marrow transplant
- Children: 500 mg/m²LPT per day for 3 days.
- Children: 1–2 ml injected into the subconjunctiva of the eye.
How to Use Carboplatin Correctly
Carboplatin will be given by a doctor or medical officer under the supervision of a doctor. This drug can be given through an IV or injection into a vein (intravenous/IV), into the peritoneal space in the abdomen, or into the subconjunctiva of the eye.
Carboplatin is usually given no more than once every 4 weeks. This is done to ensure that the bone marrow can regenerate and be able to produce the required blood cells.
Drink lots of fluids when taking carboplatin to prevent kidney problems and malaise.
If treatment with carboplatin causes nausea, you should not eat before taking treatment or eat small but frequent meals. If needed, you can contact your doctor to prescribe medication that can reduce nausea.
Before and during treatment with carboplatin, the doctor will ask you to undergo a complete blood count to see your blood cell count, liver function, and kidney function.
Interaction of Carboplatin with Other Drugs
Some drug interactions that can occur if carboplatin is used with certain drugs are:
- Decreased effectiveness and increased risk of infection from vaccines.
- Increased risk of seizures when used with phenytoin or fosphenytoin
- Increased myelosuppressive effect when used with other myelosuppressive agents, such as ciclosporon, aldesleukin, or rituxamab
- Increased risk of kidney damage, hearing loss, or impaired balance when used with aminoglycoside antibiotics or diuretics
Side Effects and Dangers of Carboplatin
Here are some side effects that can occur after using carboplatin:
- stomach ache
- Pain or feeling unwell
- Nausea and vomiting
- Muscle, joint or bone pain
- Hair loss
Tell your doctor if your side effects don't subside or get worse. See a doctor immediately if you have an allergic reaction to the drug or a more serious side effect, such as:
- Easy bruising, nosebleeds, bloody urine, bloody stools
- Tired, tired, lethargic, which is getting worse
- Jaundice or dark urine
- Numbness or tingling in the hands or feet
- Sudden ringing in the ears or deafness
- The amount of urine is very little or infrequent urination
- Injected area is red, swollen, and painful
- Fever, chills, sore throat, or thrush that doesn't go away
- Temporary blindness or decreased visual acuity
Men's strong medicine can be a solution for those of you who have sexual arousal disorders. However, also pay attention to the safety and side effects of male tonic before you use it Erectile dysfunction or erectile dysfunction is one of the causes of decreased male sexual performance.
Although it has been widely used to treat COVID-19, there are a number of dangers and side effects of favipiravir for pregnant women and fetuses. Therefore, this drug is not recommended for women who are pregnant or planning to become pregnant Favipiravir is an antiviral drug developed in Japan.
Almost all types of vaccines are at risk of side effects, including the Sinovac vaccine. Side effects of the Sinovac vaccine can include fever and pain, swelling, and redness at the injection site. However, these side effects are generally harmless and go away on their own Just like other COVID-19 vaccines, the side effects of the Sinovac vaccine that often appear are usually mild.
Blood thinners are medicines that are used to thin or improve blood flow throughout the body. In addition, blood thinners can also prevent the formation of blood clots which are the culprits for the emergence of various serious diseases, such as stroke and coronary heart disease Blood thinners are generally needed by people with certain medical conditions, such as coronary heart disease, blood vessel disease, heart rhythm disorders such as atrial fibrillation, heart valve rep
AstraZeneca vaccine or AZD1222 is a vaccine to prevent COVID-19 disease. This vaccine is the result of a collaboration between the University of Oxford and AstraZeneca which was developed since February 2020 AstraZeneca's vaccine for COVID-19 is undergoing clinical trials in the UK, Brazil and South Africa.